Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript
09:41pm, Thursday, 23'rd Apr 2026
Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
07:02pm, Thursday, 23'rd Apr 2026
While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metric
Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves
05:51pm, Thursday, 23'rd Apr 2026
Edwards Lifesciences beat Wall Street first-quarter estimates on Thursday, driven by robust demand for its artificial valves used in complex cardiac procedures, sending its shares up over 4% in
Heart-Valve Maker Edwards Lifesciences Pops On First-Quarter Beat
04:30pm, Thursday, 23'rd Apr 2026
Edwards Lifesciences stock advanced late Thursday on better-than-expected first-quarter sales and earnings.
Edwards Lifesciences Reports First Quarter Results
04:15pm, Thursday, 23'rd Apr 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, co
Is EW Overvalued? DCF Says Worth $48
07:03am, Thursday, 23'rd Apr 2026
On April 23, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company currently trading at $81.53. The stock has shown some volatility
Edwards Lifesciences' Q1 Earnings on Deck: Here's What to Expect
03:46pm, Monday, 20'th Apr 2026
EW heads into Q1 earnings with TAVR strength, rising estimates and momentum in mitral and tricuspid therapies shaping expectations.
Mirae Asset Global Investments Co. Ltd. Increases Holdings in Edwards Lifesciences Corporation $EW
05:17am, Monday, 20'th Apr 2026
Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Edwards Lifesciences Corporation (NYSE: EW) by 27.3% in the fourth quarter, according to the company in its most recent filing wit
Birch Hill Investment Advisors LLC Sells 13,385 Shares of Edwards Lifesciences Corporation $EW
03:44am, Sunday, 19'th Apr 2026
Birch Hill Investment Advisors LLC reduced its position in shares of Edwards Lifesciences Corporation (NYSE: EW) by 1.8% during the undefined quarter, according to the company in its most recent Form
Parnassus Growth Equity Fund Q1 2026 Portfolio Activity
10:11am, Friday, 17'th Apr 2026
We are actively monitoring Meta Platforms' social and data privacy risks and believe the company has made progress on strengthening its policies and enforcement. We believe the market is underestimati
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
07:05am, Thursday, 16'th Apr 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2026 after the market closes on Thursday April 23, and will hos
Scott Ullem Sells 13,000 Shares of Edwards Lifesciences (NYSE:EW) Stock
04:17am, Saturday, 11'th Apr 2026
Edwards Lifesciences Corporation (NYSE: EW - Get Free Report) CFO Scott Ullem sold 13,000 shares of the business's stock in a transaction that occurred on Thursday, April 9th. The stock was sold at an
Edwards Lifesciences (NYSE:EW) VP Donald Bobo, Jr. Sells 22,680 Shares of Stock
04:48am, Friday, 03'rd Apr 2026
Edwards Lifesciences Corporation (NYSE: EW - Get Free Report) VP Donald Bobo, Jr. sold 22,680 shares of the stock in a transaction dated Thursday, April 2nd. The shares were sold at an average price o
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market
10:47am, Thursday, 02'nd Apr 2026
Cardiovascular disease may be one of medicine’s oldest battlegrounds, but some of its most important technologies are still evolving — and not always as...
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
09:29am, Thursday, 02'nd Apr 2026
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy’ rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to...
